AlphaTON Capital Corp. - SIC # 6044 -

Ticker Exchange SIC # Website Latest Ticker
ATON Nasdaq 6044 alphatoncapital.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AlphaTON Capital Corp.

BC-Most Active Stocks - Jan 13th, 2026 8:30 am
AlphaTON Capital: Capture the Best of Telegram Economics at a Steep Discount – Initiation Report - Dec 18th, 2025 5:40 am
AlphaTON Capital Corp Issues Clarification on Anduril Industries Investment Program - Dec 17th, 2025 4:57 pm
AlphaTON Capital Corp Announces Intention to Launch Decentralized AI-Native Biotech Platform Focused on Rare Cancers - Dec 17th, 2025 8:07 am
AI Chips Update - AlphaTON Capital Expands AI Capabilities With NVIDIA B300 Integration - Dec 17th, 2025 4:37 am
AlphaTON Capital Corp Announces Historic Strategic $30 Million Investment in Anduril Industries - Dec 16th, 2025 7:00 am
Public Gateway to Telegram Economy: AlphaTON Executive Chairman Enzo Villani, Live at Nasdaq - Dec 10th, 2025 1:42 pm
AI Chips Update - AlphaTON Invests $82.5M In Nvidia-Powered AI Expansion - Nov 28th, 2025 4:37 am
AlphaTON Commits $82.5 Million to Telegram's Cocoon AI, Including Nvidia GPU Cluster - Nov 26th, 2025 8:43 am
Wall Street Eyes Monetary Policy Cues, Driving Premarket Gains for US Equity Futures - Nov 24th, 2025 7:08 am
HIT: Strong 3Q & Outlook, With New Solutions Recently Introduced, Others Being Developed - Nov 12th, 2025 5:13 am
AlphaTON’s Cyncado Therapeutics and Australia’s ADDRI to Launch Investigator-Initiated Mesothelioma Clinical Trial of TT-4, Complementing U.S. Plans - Nov 12th, 2025 5:00 am
Health In Tech and AlphaTON Capital to Unveil Blockchain Healthcare Vision at Web Summit Lisbon - Nov 11th, 2025 5:00 am
Complete Tumor Regressions Observed in Preclinical Models with Co-administration of Cyncado’s A2B and A2A Receptor Antagonists and Cancer Vaccines - Nov 7th, 2025 5:00 am
Can Telegram Crypto Make a Come Back? TON’s Corporate Treasury Plans Could See TON Price Hit $3.50 in November - Oct 23rd, 2025 2:49 am
Health In Tech, AlphaTON Partner to Develop ‘HITChain’ Blockchain Platform for Healthcare Claims on TON - Oct 11th, 2025 7:48 am
Top Midday Gainers - Oct 8th, 2025 12:09 pm
Sector Update: Health Care Stocks Advance Wednesday Afternoon - Oct 8th, 2025 11:42 am
Traders Eye Fed Minutes, Driving Muted Premarket Action for US Equity Futures - Oct 8th, 2025 7:14 am
TON on Telegram Ecosystem: AlphaTON Capital CIO Enzo Villani, Live at Nasdaq - Oct 7th, 2025 7:39 am